Model for predicting immunotherapy based on M2 macrophage infiltration in TNBC

IntroductionCompared to other types of breast cancer, triple-negative breast cancer (TNBC) does not effectively respond to hormone therapy and HER2 targeted therapy, showing a poor prognosis. There are currently a limited number of immunotherapeutic drugs available for TNBC, a field that requires ad...

Full description

Bibliographic Details
Main Authors: Haoming Wu, Jikun Feng, Wenjing Zhong, Xiazi Zouxu, Zhengchong Xiong, Weiling Huang, Chao Zhang, Xi Wang, Jiarong Yi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151800/full